A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.
Inclusion Criteria:
Exclusion Criteria:
Brandýs nad Labem-Stará Boleslav, 25001, Czechia
Krnov, 79401, Czechia
Prague, 11000, Czechia
Prague, 149 00, Czechia
Prague, 181 00, Czechia
Praha 4 - Krc, 140 59, Czechia
Chihuahua City, 31217, Mexico
Cuernavaca, 62250, Mexico
Guadalajara, 04460, Mexico
Monterrey, 64460, Mexico
Tampico, 89000, Mexico
Bialystok, 15-404, Poland
Bialystok, 15-445, Poland
Gdansk, 80-546, Poland
Lodz, 90-242, Poland
Lublin, 20-333, Poland
Lublin, 20-538, Poland
Poznan, 61-655, Poland
Poznan, 61-853, Poland
Ruda Śląska, 41-709, Poland
Szczecin, 70-506, Poland
Alba Iulia, 510053, Romania
Baia Mare, 430222, Romania
Iași, 700547, Romania
Oradea, 410159, Romania